Setrusumab Trial Update Disappoints Investors Despite Continued Clinical Progress
11 months ago
By
Ana
In
Investments
Venture Capital
aTyr Pharma Added to Russell 2000® and Russell 3000® Indexes, Reflecting Growth and Market Confidence
12 months ago
By
Ana
In
Biopharma Highlights
Innovation
Investments
People
Pharma Industry Updates
Oncolytics Biotech Highlights Growing Investor Interest as Global Oncology Drug Market Surpasses $900 Billion Forecast
12 months ago
By
Ana
In
Biopharma Highlights
Clinical Trials
Innovation
Investments
Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools
1 year ago
By
Ana
In
AI & Data
Investments
Go to Inverstment